Chris Pasquale

Stock Analyst at Guggenheim

(0.38)

# 4,220

Out of 5,049 analysts

3

Total ratings

n/a

Success rate

-9.93%

Average return

Main Sectors:

Top Industries:

Medical Devices Medical Instruments & Supplies

Stocks Rated by Chris Pasquale

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DXCM DexCom	Upgrades: Buy	$145	$61.18	+137.01%	1	Jan 7, 2022
	COO The Cooper Companies	Upgrades: Buy	$124	$69.08	+79.14%	1	Jan 3, 2022
	PRCT PROCEPT BioRobotics	Initiates: Buy	$45	$35.02	+28.50%	1	Oct 11, 2021

DexCom

Jan 7, 2022

Upgrades: Buy

Price Target: $145

Current: $61.18

Upside: +137.01%

The Cooper Companies

Jan 3, 2022

Upgrades: Buy

Price Target: $124

Current: $69.08

Upside: +79.14%

PROCEPT BioRobotics

Oct 11, 2021

Initiates: Buy

Price Target: $45

Current: $35.02

Upside: +28.50%